© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Ascendis Pharma A/S (ASND) shows an Average True Range (ATR) of 9.81 and an Enterprise Value of 7.82B. Its average trading volume over the past 3 months is 578.98K, indicating liquidity. These fundamental metrics provide insight into ASND's underlying financial health and market activity.
Ascendis Pharma A/S (ASND) technical indicators as of December 22, 2025: the SMA 20 is -3.38%, SMA 50 at -2.82%, and SMA 200 at 9.74%. The RSI 14 value is 44.76, suggesting its current momentum. These technical analysis signals help assess ASND's price trends and potential future movements.
Ascendis Pharma A/S (ASND) stock performance overview as of December 22, 2025: The 52-week high is $229.94 (currently -13.03% below), and the 52-week low is $118.03 (currently 69.44% above). Over the past year, ASND's performance is 53.99%, compared to the S&P 500's 12.87% change.
According to market data, Ascendis Pharma A/S (ASND) stock's recent performance metrics show that over the last month, ASND is -7.89%, with a Year-to-Date (YTD) performance of 45.27%. Over the past year, the stock has seen a 53.99% change. These figures summarize ASND's price movements across various periods, reflecting its historical returns.
According to current financial data, ASND stock's P/E (TTM) ratio is -39.61, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ASND, including P/S (21.81), P/B (-57.26), and P/FCF (-62.65), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.